DIMA Biotechnology Ltd.'s Anti-B7-H3 (enoblituzumab biosimilar) mAb is a Human monoclonal antibody. The Anti-B7-H3 (enoblituzumab biosimilar) mAb Antibody was generated using CD276 as the antigen. It reacts with Human. This antibody has been shown to work in applications such as: EIA, Immunoassay, ELISA, and Flow Cytometry.